Hypotensive effect of a newly identified peptide, proadrenomedullin N- terminal 20 peptide

Hypertension

Volumn 28, Issue 3, 1996, Pages 325-329

  Shimosawa, Tatsuo ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

norepinephrine; pithed rat; sympathetic nerve activity

Indexed keywords

ADRENOMEDULLIN; NORADRENALIN; PEPTIDE; PROADRENOMEDULLIN; RECOMBINANT PROADRENOMEDULLIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DEPRESSOR RESPONSE; ELECTROSTIMULATION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NORADRENALIN RELEASE; PEPTIDE ANALYSIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE;

EID: 0029837338     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.325     Document Type: Article

References (24)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
2. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun. 1993;194: 720-725.
3. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun. 1993;195:921-927.
4. Washimine H, Kitamura K, Ichiki Y, Yamamoto Y, Kangawa K, Matsuo H, Eto T. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem Biophys Res Commun. 1994;202:1081-1087.
5. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Comm. 1994;203:719-726.
6. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994;201: 1160-1166.
7. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993;241:271-273.
8. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 1993;196:245-251.
9. Jougasaki M, Wei CM, Aarhus LL, Heublein DM, Sandberg SM, Burnett J Jr. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol. 1995;268:F657-F663.
10. Feng CJ, Kang B, Kaye AD, Kadowitz PJ, Nossaman BD. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci. 1994;55:L433-L438.
11. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem. 1995; 270:4412-4417.
12. Hirata Y, Hayakawa H, Suzuki Y, Suzuki E, Ikenouchi H, Kohmoto O, Kimura K, Kitamura K, Eto T, Kangawa K, Matsuo H, Omata M. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension. 1995;25:790-795.
13. Kitamura K, Kangawa K, Ishiyama Y, Washimine H, Ichiki Y, Kawamoto M, Minamino N, Matsuo H, Eto T. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett. 1994;351:35-37.
14. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest. 1995;96:1672-1676.
15. Lippton H, Gao Y, Lin B, Heaton J, Ferrara J, DeVito M, Granger T, Pigott J, Chang JK, Hyman A. Prodepin: a new product of the adrenomedullin (ADM) gene has systemic vasodilator activity. Life Sci. 1994;54:L409-L412.
16. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175-195.
17. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
18. Ganten D, Paul M, Lang RE. The role of neuropeptides in cardiovascular regulation. Cardiovasc Drug Ther. 1991;5:119-130.
19. Gillespie JS, Maclaren A, Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol. 1970;40:257-267.
20. Ito Y, Noda H, Isaka M, Ando K, Sato Y, Fujita T. Norepinephrine responsiveness in patients with borderline hypertension under three different sodium balances. Clin Exp Hypertens A. 1989;1:363-370.
21. Parkes DG. Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol. 1995;268:H2574-H2578.
22. Jougasaki M, Wei CM, McKinley LJ, Burnett J Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 1995;92:286-289.
23. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest. 1994;94:2158-2161.
24. Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, Minami M, Yasunari K, Yoshikawa J. Plasma adrenomedullin concentrations in essential hypertension. Hypertension. 1996;27: 102-107.